Welcome back to our blog series on National Member News!

 

We are very excited about getting our National Member news out to the world, so more people can find out what it is happening in each country and each organisation! We caught up with Andreas Panteli from Lupus Suisse, who talked to us about the great work the organisation is doing, the needs of lupus patients in Switzerland,  COVID19 and so much more!

 

How do you keep in touch with or have contact with your members?

 

We send our Lupus Magazine to around 550 of our members twice per year; from 2021 onwards, this will move to once a year. We send our members 5-6 e-mails and post letters per years. We also have workshops and conferences twice a year. This is an area we are looking to improve, so we can have faster communication with our members.

 

 

 

 

 

 

 

 

 

 

 

Photo of Magdalena from an article within the Lupus Suisse magazine sharing thoughts on seeing life in a positive way

 

Did you have any special meetings or webinars during the past year (World Lupus Day, Rare Disease Day, Annual General Meeting etc)?

 

Yes! We had our Annual General meeting on April 24th. We also had 2 doctor led webinars:

 

 

 

In 2020 we had no General assembly, doctors’ webinars or workshops

 

Has it been difficult to keep connected with your members during the Covid19 pandemic?

 

Yes, face-to-face interactions have not been possible. The French part of Switzerland tried to use Zoom, but this didn’t work very well due to technical and personal issues. WhatsApp and messages seem to have more been useful than voice or video interactions during the covid19 pandemic for our group.

 

Many regional sub-groups found it difficult to keep in touch, as lupus members preferred to stay away from gatherings and interactions.

 

          Photo from a past Lupus Suisse event 

 

 

Have there been any circumstances during the pandemic that changed the way of living with lupus?

 

 

 Lupus Suisse members preferred to stay away from gatherings. This was truer for lupus patients who are members of Lupus Suisse, than for people who were not lupus patients.

 

We observed that for newly diagnosed patients there was increased care, as recurring appointments were postponed during in the first lockdown. Care was more organised due to the strict appointment window. Caregivers had restricted access at the beginning, now this is back to normal.

 

 

 

Photo of Lerna –  from an article within the Lupus Suisse magazine sharing ideas & tips for how to cook healthy meals 

 

Has Digital Health improved or changed in your country?

 

Digital health has not changed in the country as a result of the pandemic.

PCR covid19 or lateral flow test results are sometimes sent via SMS or e-mail, there have been some issues with this however and some people had to revisit the test centre to get their results.

 

What would you most need as support in your country for lupus?

 

We are currently missing groups and meeting face to face; we would like to see group meetings coming back, activity increasing, face to face workshops returning and interactions resuming.

 

Diagnosis in Switzerland can take a long time and may not be accurate. We would like to see shorter times to diagnosis and increasing accuracy of diagnoses.

 

Doctors currently must frequently switch medicines to find the one that works best for the patient. We need this situation to be improved for patients; it would be better for patients if doctors could predict which medicine would work for what patient.

 

Is there anything you think Lupus Europe could help your organisation with?

 

Yes! Lupus Europe could help our organisation through exchanging ideas and resources and through involvement in clinical or other studies.

 

Is there any topic/theme/area that you think Lupus Europe should focus on, on something where European collaboration would make sense?

 

Yes! We think there should be European collaboration on increasing funding for new therapies for lupus.

 

Are you aware of the Lupus Europe Member Capacity Building Program?

No!

 

Could you tell us a bit about a dream you have as a group?

  

We dream of bringing most lupus patients in Switzerland closer, of creating a community. We dream of lupus patients in Switzerland being offered the services they need to improve their social position and quality of life. We dream of being advocates and the patient voices for lupus patients in Switzerland. We want lupus patients to be able to have access to doctors they feel comfortable with; that they can choose their doctors. We dream of integrating healthcare professionals, creating a lupus network of healthcare professionals’ network with specialists like rheumatologists, immunologists et cetera that all lupus patients in Switzerland will be able to access. 

Live Facebook Feed

Comments Box SVG iconsUsed for the like, share, comment, and reaction icons

💜 We've taken part in the EULAR PARE Conference 2026 in Brussels! And what an interesting opportunity to discuss the future of AI in healthcare!

🌍 Bringing together more than 100 delegates and speakers from across Europe and beyond, the conference explored some of the most important questions surrounding artificial intelligence in rheumatology and patient advocacy.

From the opportunities and risks of AI to health inequalities, accessibility and European health policy, the discussions highlighted why patient perspectives must be part of the conversation.

🤩 We were particularly proud to see Jeanette Andersen, Chair of the Lupus Europe Board, sharing our experience with #LupusGPT in her presentation, “AI as a Partner in Care: Empowering the RMD Community with Information”.

💡 Jeanette explained how #LupusGPT was developed with patients and clinicians to offer free, multilingual access to reliable lupus information based on validated sources.

She also introduced #EasyLupus, which provides the same trusted information in simpler language, highlighting why accessibility must be considered when developing AI tools.

But one of the most important messages from her presentation went beyond technology.

💜 Patient organisations have much more to contribute to AI than simply using tools developed by others.

As Jeanette highlighted, patient organisations bring lived experience, knowledge of unmet needs, trusted information and an understanding of the barriers people face when accessing health information.

Technology alone cannot tell us what patients really need or what makes a tool genuinely useful.

Patients and patient organisations should not simply be users of AI. They should help shape its development.

👏 A big thank you to EULAR PARE for bringing together so many different perspectives and creating space for meaningful discussions about the future of healthcare and patient involvement!
...

💜 Weve taken part

🦋 One of the greatest strengths of patient organisations is the support, understanding and sense of community they offer to people living with lupus. 💜

🇧🇬 A great example comes from Организация на пациентите с ревматологични заболявания, who shared their psychological support initiative at the #LupusConvention!

💜 Launched in December 2025, this pilot project provides a safe and supportive space where participants can share their experiences and discuss the challenges of living with lupus, from fatigue and anxiety to relationships and everyday life.

👥 Led by a clinical psychologist, the group currently brings together six women. The project is expected to run until December 2026, while the organisation explores funding opportunities to continue and expand the initiative.

Thank you to our Bulgarian colleagues for sharing their experience, and congratulations on the amazing job you are doing! ❤️

🌍 This is just one example of the valuable work patient organisations are doing across Europe, often responding to needs that go beyond medical care. We'll share more in the coming days!

💜 Are you living with lupus? You don't have to navigate everything alone! Your national lupus organisation may offer information, support, activities and opportunities to connect with others who understand your experiences.

🔗 Find your national lupus organisation and get in touch:
lupus-europe.org/lupus-members/
...

Image attachment
Image attachment

💜 Young people living with lupus are not only the future of patient advocacy. Their voices matter today!

On 23 and 24 October, LUPUS EUROPE was delighted to be represented at the first 𝗘𝗣𝗙 𝗬𝗼𝘂𝘁𝗵 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝟮𝟬𝟮𝟲 in Brussels by Ana Rita Vieira, from the LUPUS EUROPE Youth Group, and Lena Koskina, LUPUS EUROPE's Youth Group Coordinator.

🌍 Organised by European Patients' Forum and its EPF Youth Group, the Congress brought together young patient advocates from across Europe to explore the challenges facing young people living with chronic conditions, from economic uncertainty and climate change to the barriers they encounter when trying to influence healthcare decisions.

🌟 One particularly important question ran through the discussions: 𝗵𝗼𝘄 𝗱𝗼 𝘄𝗲 𝗺𝗼𝘃𝗲 𝗯𝗲𝘆𝗼𝗻𝗱 𝘀𝗶𝗺𝗽𝗹𝘆 𝗴𝗶𝘃𝗶𝗻𝗴 𝘆𝗼𝘂𝗻𝗴 𝗽𝗲𝗼𝗽𝗹𝗲 𝗮 𝘀𝗲𝗮𝘁 𝗮𝘁 𝘁𝗵𝗲 𝘁𝗮𝗯𝗹𝗲, 𝗮𝗻𝗱 𝗲𝗻𝘀𝘂𝗿𝗲 𝘁𝗵𝗲𝘆 𝗵𝗮𝘃𝗲 𝗮 𝗿𝗲𝗮𝗹 𝘀𝗮𝘆 𝗶𝗻 𝘁𝗵𝗲 𝗱𝗲𝗰𝗶𝘀𝗶𝗼𝗻𝘀 𝗯𝗲𝗶𝗻𝗴 𝗺𝗮𝗱𝗲❓

The conversations also highlighted something easily overlooked: 𝗺𝗲𝗮𝗻𝗶𝗻𝗴𝗳𝘂𝗹 𝗽𝗮𝗿𝘁𝗶𝗰𝗶𝗽𝗮𝘁𝗶𝗼𝗻 𝗿𝗲𝗾𝘂𝗶𝗿𝗲𝘀 𝗺𝗼𝗿𝗲 𝘁𝗵𝗮𝗻 𝗮𝗻 𝗶𝗻𝘃𝗶𝘁𝗮𝘁𝗶𝗼𝗻. Young people living with chronic conditions are often balancing their health with education, employment and financial pressures. Advocacy opportunities need to recognise those realities, and not be accessible only to those who can afford the time and resources to participate.

🦋 At LUPUS EUROPE, supporting the Youth Group means actively helping create those opportunities, connecting young advocates with others across Europe and ensuring their perspectives can meaningfully contribute to the work we do.

Young people living with lupus are already advocates, bringing their experiences, ideas and knowledge into conversations that matter.

💜 Thank you to European Patients' Forum and its EPF Youth Group for bringing everyone together, and to Rita and Lena for representing LUPUS EUROPE at this important Congress!
...

💜 Young people li

🔊 Hot off the press!

💜 Treatment adherence is important, complex and multifactorial.

But understanding the importance of treatment adherence is not the same as knowing how to support it in everyday clinical practice.

That’s why, in 2020, EULAR published its Points to Consider for the prevention, screening, assessment and management of nonadherence to treatment in people with rheumatic and musculoskeletal diseases.

But having recommendations is only the first step. How can we ensure they become part of everyday clinical practice?

🤩 An interesting new viewpoint published in EULAR Rheumatology Open, co-authored by Jeanette Andersen, Chair of the Lupus Europe Board, now explores the challenges of putting these recommendations into routine rheumatology care.

The article highlights that nonadherence is not simply a matter of individual patient behaviour. Concerns about treatment, practical difficulties, access to medication, socioeconomic circumstances and communication with healthcare professionals can all play a role.

The authors highlight five key priorities for putting adherence support into routine rheumatology practice:

🔹 Assessment: Identifying adherence behaviours and the barriers behind them.
🔹 Monitoring: Reassessing adherence over time, as it may change throughout the disease course.
🔹 Shared decision-making: Discussing patients’ preferences, expectations and concerns through non-judgemental communication.
🔹 Multidisciplinary care: Involving the wider healthcare team according to individual needs.
🔹 Training: Making adherence support part of rheumatology education and professional development.

💜 The challenge is not the lack of recommendations, but making adherence assessment and support a routine part of rheumatology care.

📖 Read the open-access viewpoint: doi.org/10.1016/j.ero.2026.100261
...

Image attachment
Image attachment
Image attachment
Image attachment
LUPUS EUROPE Uniting people with Lupus throughout Europe
Send